Jim Simons's position in TG Therapeutics is currently worth $4.73 Million. That's 0.01% of their equity portfolio (1387th largest holding). The first TG Therapeutics trade was made in Q3 2014. Since then Jim Simons bought shares eleven more times and sold shares on twelve occasions. The investor's estimated purchase price is $13.8 Million, resulting in a loss of 66%.